×







We sell 100% Genuine & New Books only!

Newer Drugs, 2/E at Meripustak

Newer Drugs, 2/E by Dhikav, Elsevier Science

Books from same Author: Dhikav

Books from same Publisher: Elsevier Science

Related Category: Author List / Publisher List


  • Price: ₹ 580.00/- [ 5.00% off ]

    Seller Price: ₹ 551.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Dhikav
    PublisherElsevier Science
    Edition2
    ISBN9788131229903
    Pages160
    LanguageEnglish
    Publish YearJanuary 2011

    Description

    Elsevier Science Newer Drugs, 2/E by Dhikav

    Study of newer drugs takes lot of time, and there is no unified source of newer drugs. One has to extract such information in bigger books like Current Medical Diagnosis and Treatment, Harrisons? Principles of Internal Medicine, or books of pharmacology like Katzung?s/Goodman & Gillman?s. Newer drugs have also become very relevant in postgraduate medical entrance examinations (PGMEE). Therefore, a handy update is needed. Reading newer drugs in textbooks consumes too much of time and is becoming a challenge in a short span of time. A small handbook like ?newer drugs? meets requirements of PGMEE aspirants and also undergraduates and practicing clinicians. A newer drug is a book which contains comprehensive information about newer drugs at one place. Students don?t have to search different textbooks for new drugs. In Postgraduate Medical Entrance Examinations, generally 10% of total pharmacology questions are from new drugs. Also it is a handy book for practitioners and students of pharmacology and medicine for recent updates on newer drugs.


    Key Features:-

    • Thorough revision
    • Additional details about approved drugs
    • Newly approved drugs
    • In-depth coverage of monoclonal antibodies
    • Drugs under development or clinical evaluation


    Book Successfully Added To Your Cart